Physician profile
Andrew Ian Brill
NPI 1225055205
$345,343.24
in general payments reported to CMS, 2019-2025
14 companies · $30K in 2025
The $30K reported for 2025 was more than what 96% of Urogynecology and Reconstructive Pelvic Surgery (Urology) providers received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2021: $77K · 2022: $72K · 2023: $60K · 2024: $35K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $125K · Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $125,000.00 |
| Food and Beverage | $125.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $245,545.18 | 2021-2025 | |
| Abbvie INC. | $46,112.61 | 2019 | |
| Meditrina | $27,250.00 | 2021-2022 | |
| Medical Device Business Services, INC. | $17,780.24 | 2019 | |
| Karl Storz Endoscopy-America | $5,455.78 | 2019-2023 | N.A. |
| Boston Scientific Corporation | $1,567.79 | 2021-2022 | |
| Caldera Medical, INC | $950.00 | 2019 | |
| Conmed Corporation | $145.83 | 2019 | |
| Gynesonics, INC. | $137.99 | 2019 | |
| Amag Pharmaceuticals, INC. | $107.87 | 2019 | |
| Myovant Sciences INC. | $103.62 | 2021-2022 | |
| Allergan, INC. | $103.59 | 2019 | |
| Ethicon US, LLC | $48.20 | 2019 | |
| Sumitomo Pharma America, INC. | $34.54 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Brill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.